Trial Details

COMPLETED
Basic Information
Clinical ID c425
Identifier NCT01341808
Trial Title Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease|Crohn's Disease|Ulcerative Colitis|Hepatitis A
Interventions BIOLOGICAL: Epaxal Berna (virosomal hepatitis A vaccine)
Participant Information
Sponsor Asan Medical Center
City Seoul
Country/Region Korea, Republic of
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2025-04-11
Primary Completion Date 2025-02-13
Completion Date 2025-03-13